Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02864381
Title GS-5745 Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | HUN | GBR | FRA | ESP | BEL | AUS


No variant requirements are available.